Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc.

23-1158Court of Appeals for the Federal Circuit14.12.2022

Gesamter Gesetzestext

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
TRIS PHARMA, INC.,
Plaintiff-Appellee
v.
TEVA PHARMACEUTICALS USA, INC.,
Defendant-Appellant
______________________
2023-1158
______________________
Appeal from the United States District Court for the
District of New Jersey in No. 2:20-cv-05212-KM-ESK,
Judge Kevin McNulty.
______________________
ON MOTION
______________________
O R D E R
Teva Pharmaceuticals USA, Inc. moves to voluntarily
dismiss this appeal pursuant to Rule 42 of the Federal
Rules of Appellate Procedure, stating that “[n]o costs are
due” and that Tris Pharma, Inc. does not oppose the mo-
tion. Mot. at 1.
Upon consideration thereof,
Case: 23-1158 Document: 5 Page: 1 Filed: 12/14/2022

-- 1 of 2 --

TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. 2
I T I S O RDERED T HAT :
(1) The motion is granted. The appeal is dismissed.
(2) The parties shall bear their own costs.
December 14, 2022
Date
F OR THE COURT
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court
ISSUED AS A MANDATE: December 14, 2022
Case: 23-1158 Document: 5 Page: 2 Filed: 12/14/2022

-- 2 of 2 --

Setzen Sie Ihre Recherche in ChatGPT oder Claude fort

Verbinden Sie Omnilex, um den Rechtskorpus über Ihren KI-Assistenten zu durchsuchen.